Newsroom

Recent News Releases

June 8, 2018 6/8/2018 Positive clinical phase III results of vortioxetine in Japanese patients

June 8, 2018 6/8/2018 Takeda Announces Term Loan Credit Agreement and Amendment to Bridge Credit Agreement in Connection with Proposed Shire Acquisition

June 6, 2018 6/6/2018 Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period

June 3, 2018 6/3/2018 Takeda Highlights Favorable Safety Profile of Entyvio^® (vedolizumab) Through Comparative Real-World Data Versus TNFα-Antagonist Therapy in Ulcerative Colitis and Crohn’s Disease

May 31, 2018 5/31/2018 ASKA and Takeda Enter into Licensing Agreement for Relugolix in Women's Health Indications

SEE ALL NEWS AND RELEASES >

Featured Topics

Shonan Health Innovation Park Grand Opening

Learn more

Takeda’s CSR in Action: Helping Save Children's Lives Through Immunization

Learn more

2017 Winners and Finalists Honored at Awards Ceremony at NYAS in New York City

Learn more

Takeda Exhibits Innovation Park Vision at Bio Japan 2017

Learn more

Strengthening our global production network in Oranienburg

Learn more

FOR MORE TOPICS>

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.